Skip navigation

Chemical Boronic Acids

1–50 of 520 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. Bortezomib cell death Bortezomib results in increased cell death 1: Homo sapiens Oropharynx | Cell Line, Tumor
6 genes: BNIP3 | CDKN1B | CTSD | FAF1 | HMOX1 | TRAF6
1
2. Bortezomib cell death gemcitabine Bortezomib promotes the reaction [gemcitabine results in increased cell death] 1: Homo sapiens Oropharynx | Cell Line, Tumor
6 genes: BNIP3 | CDKN1B | CTSD | FAF1 | HMOX1 | TRAF6
1
3. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Lymphoid Tissue | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
2
4. Bortezomib apoptotic process sorafenib sorafenib promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Lymphoid Tissue | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
5. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Myeloid Cells | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
3
6. Bortezomib apoptotic process Sirolimus Sirolimus inhibits the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Myeloid Cells | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
7. Bortezomib apoptotic process arsenic trioxide Bortezomib inhibits the reaction [arsenic trioxide results in increased apoptotic process] 1: Homo sapiens Bone Marrow | Myeloid Cells | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
8. Bortezomib cell cycle arsenic trioxide Bortezomib promotes the reaction [arsenic trioxide results in decreased cell cycle] 1: Homo sapiens Stomach | Cell Line, Tumor
62 genes: ANAPC11 | ANAPC5 | ARF6 | ARL8A | ATM | BECN1 | BIRC5 | BRCA1 | BRCA2 | BRCC3 | CCAR1 | CCNB1 | CCND1 | CCND2 | CCNF | CCNG2 | CCPG1 | CDC23 | CDC34 | CDC37 | CDC42 | CDK1 | CDK2 | CDKN1A | CDKN1B | CDT1 | CGREF1 | CHAF1A | CHFR | DDIT3 | DLGAP5 | E2F1 | FANCD2 | GADD45A | GNAI3 | H2AFX | HAUS6 | IKZF1 | KAT2B | KATNAL1 | LIG4 | MAPK1 | MAPK3 | MCM7 | MDC1 | MKI67 | NEDD1 | PRKCD | RALA | RB1 | RB1CC1 | RPS6KB1 | SMC1A | SMC3 | SUV39H1 | TFDP1 | TNKS | TP53 | TRP53 | VCP | WEE1 | ZMYND11
1
9. Bortezomib cell proliferation Bortezomib results in decreased cell proliferation 1: Homo sapiens Tumor Cells, Cultured
46 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | YPEL5 | ZMYND11
1
10. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Blood | Tumor Cells, Cultured
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
11. Bortezomib apoptotic process pyrazolanthrone pyrazolanthrone inhibits the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens Blood | Tumor Cells, Cultured
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
12. Bortezomib apoptotic process TNFSF10 [TNFSF10 protein co-treated with Bortezomib] results in increased apoptotic process 1: Homo sapiens Prostate | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
13. Bortezomib apoptotic process TNFSF10 Bortezomib promotes the reaction [TNFSF10 protein results in increased apoptotic process] 1: Homo sapiens HCT116 Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
14. Bortezomib apoptotic process BAX | TNFSF10 Bortezomib inhibits the reaction [BAX mutant form inhibits the reaction [TNFSF10 protein results in increased apoptotic process]] 1: Homo sapiens HCT116 Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
15. Bortezomib apoptotic process TNFSF10 [TNFSF10 protein co-treated with Bortezomib] results in increased apoptotic process 1: Mus musculus Embryo, Mammalian | Fibroblasts | Cell Line
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
16. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Lymphocytes | Tumor Cells, Cultured
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
2
17. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens B-Lymphocytes | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
4
18. Bortezomib apoptotic process HSPB1 HSPB1 protein inhibits the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens B-Lymphocytes | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
19. Bortezomib apoptotic process docetaxel Bortezomib inhibits the reaction [docetaxel results in increased apoptotic process] 1: Homo sapiens Pancreas | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
20. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Pancreas | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
6
21. Bortezomib apoptotic process docetaxel [Bortezomib co-treated with docetaxel] results in increased apoptotic process 1: Homo sapiens Pancreas | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
22. Bortezomib cell cycle docetaxel Bortezomib inhibits the reaction [docetaxel results in increased cell cycle] 1: Homo sapiens Pancreas | Cell Line, Tumor
62 genes: ANAPC11 | ANAPC5 | ARF6 | ARL8A | ATM | BECN1 | BIRC5 | BRCA1 | BRCA2 | BRCC3 | CCAR1 | CCNB1 | CCND1 | CCND2 | CCNF | CCNG2 | CCPG1 | CDC23 | CDC34 | CDC37 | CDC42 | CDK1 | CDK2 | CDKN1A | CDKN1B | CDT1 | CGREF1 | CHAF1A | CHFR | DDIT3 | DLGAP5 | E2F1 | FANCD2 | GADD45A | GNAI3 | H2AFX | HAUS6 | IKZF1 | KAT2B | KATNAL1 | LIG4 | MAPK1 | MAPK3 | MCM7 | MDC1 | MKI67 | NEDD1 | PRKCD | RALA | RB1 | RB1CC1 | RPS6KB1 | SMC1A | SMC3 | SUV39H1 | TFDP1 | TNKS | TP53 | TRP53 | VCP | WEE1 | ZMYND11
1
23. Bortezomib cell proliferation docetaxel Bortezomib promotes the reaction [docetaxel results in decreased cell proliferation] 1: Homo sapiens Pancreas | Cell Line, Tumor
46 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | YPEL5 | ZMYND11
1
24. Bortezomib cell proliferation Bortezomib results in decreased cell proliferation 1: Homo sapiens Pancreas | Cell Line, Tumor
46 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | YPEL5 | ZMYND11
2
25. Bortezomib cell proliferation docetaxel docetaxel promotes the reaction [Bortezomib results in decreased cell proliferation] 1: Homo sapiens Pancreas | Cell Line, Tumor
46 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | YPEL5 | ZMYND11
1
26. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Pancreas
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
2
27. Bortezomib apoptotic process docetaxel Bortezomib promotes the reaction [docetaxel results in increased apoptotic process] 1: Homo sapiens Pancreas
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
28. Bortezomib cell proliferation Bortezomib results in decreased cell proliferation 1: Homo sapiens Pancreas
46 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | YPEL5 | ZMYND11
2
29. Bortezomib cell proliferation docetaxel docetaxel promotes the reaction [Bortezomib results in decreased cell proliferation] 1: Homo sapiens Pancreas
46 genes: ACE | AKT1 | AR | BAK1 | BAX | BCL2 | BCL2L1 | BIN1 | BRCA2 | CD5 | CDK1 | CREBBP | CTNNB1 | CUL1 | CXCL1 | DLGAP5 | EPO | ERBB2 | GSK3B | HRAS | KRTAP21-1 | LIG4 | MAP2K1 | MCM7 | MKI67 | MYC | NAB2 | NUMB | NUPR1 | PDXK | POC1B | PPARD | PRKDC | PTPN6 | RAF1 | SKP2 | SRRT | STAT3 | TCF19 | TCF7L2 | TFDP1 | TNF | TP53 | VEGFA | YPEL5 | ZMYND11
1
30. Bortezomib apoptotic process alvocidib [alvocidib co-treated with Bortezomib] results in increased apoptotic process 1: Homo sapiens K562 Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
31. Bortezomib apoptotic process alvocidib [alvocidib co-treated with Bortezomib] results in increased apoptotic process 1: Homo sapiens Blood | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
32. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens K562 Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
2
33. Bortezomib apoptotic process Dichlororibofuranosylbenzimidazole Dichlororibofuranosylbenzimidazole promotes the reaction [Bortezomib results in increased apoptotic process] 1: Homo sapiens K562 Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
34. Bortezomib regulation of mitochondrial membrane potential alvocidib [alvocidib co-treated with Bortezomib] results in decreased regulation of mitochondrial membrane potential 1: Homo sapiens Blood | Cell Line, Tumor
5 genes: BAK1 | BAX | BCL2 | BCL2L1 | SOD2
1
35. Bortezomib regulation of mitochondrial membrane potential alvocidib [alvocidib co-treated with Bortezomib] results in decreased regulation of mitochondrial membrane potential 1: Homo sapiens K562 Cells
5 genes: BAK1 | BAX | BCL2 | BCL2L1 | SOD2
1
36. Bortezomib apoptotic process alvocidib [alvocidib co-treated with Bortezomib] results in increased apoptotic process 1: Homo sapiens U937 Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
37. Bortezomib regulation of mitochondrial membrane potential alvocidib [alvocidib co-treated with Bortezomib] results in decreased regulation of mitochondrial membrane potential 1: Homo sapiens U937 Cells
5 genes: BAK1 | BAX | BCL2 | BCL2L1 | SOD2
1
38. Bortezomib apoptotic process alvocidib [alvocidib co-treated with Bortezomib] results in increased apoptotic process 1: Homo sapiens HL-60 Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
39. Bortezomib apoptotic process alvocidib [alvocidib co-treated with Bortezomib] results in increased apoptotic process 1: Homo sapiens Jurkat Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
40. Bortezomib apoptotic process alvocidib [alvocidib co-treated with Bortezomib] results in increased apoptotic process 1: Homo sapiens B-Lymphocytes | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
41. Bortezomib apoptotic process alvocidib [alvocidib co-treated with Bortezomib] results in increased apoptotic process 1: Homo sapiens T-Lymphocytes | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
42. Bortezomib apoptotic process 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole Bortezomib promotes the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased apoptotic process] 1: Homo sapiens Blood | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
43. Bortezomib regulation of mitochondrial membrane potential 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole [Bortezomib co-treated with 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole] results in decreased regulation of mitochondrial membrane potential 1: Homo sapiens Blood | Cell Line, Tumor
5 genes: BAK1 | BAX | BCL2 | BCL2L1 | SOD2
1
44. Bortezomib apoptotic process 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | BCL2 [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole co-treated with Bortezomib] inhibits the reaction [BCL2 protein results in decreased apoptotic process] 1: Homo sapiens Blood | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
45. Bortezomib apoptotic process 1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole co-treated with Bortezomib] results in increased apoptotic process 1: Homo sapiens Blood | Tumor Cells, Cultured
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
46. Bortezomib apoptotic process Bortezomib results in increased apoptotic process 1: Homo sapiens Hematopoietic Stem Cells
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
47. Bortezomib apoptotic process carboxycinnamic acid bishydroxamide Bortezomib promotes the reaction [carboxycinnamic acid bishydroxamide results in increased apoptotic process] 1: Homo sapiens Colon | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
48. Bortezomib apoptotic process romidepsin Bortezomib promotes the reaction [romidepsin results in increased apoptotic process] 1: Homo sapiens Colon | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
49. Bortezomib apoptotic process carboxycinnamic acid bishydroxamide Bortezomib promotes the reaction [carboxycinnamic acid bishydroxamide results in increased apoptotic process] 1: Homo sapiens Stomach | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
50. Bortezomib apoptotic process romidepsin Bortezomib promotes the reaction [romidepsin results in increased apoptotic process] 1: Homo sapiens Stomach | Cell Line, Tumor
122 genes: ABL1 | AIFM1 | AIM2 | AKT1 | ARRB1 | ATG5 | ATM | BAG3 | BAK1 | BAX | BBC3 | BCL2 | BCL2A1 | BCL2A1A | BCL2L1 | BCL2L11 | BCL2L2 | BECN1 | BID | BIK | BIRC2 | BIRC3 | BIRC5 | BIRC7 | BNIP3 | BRCA1 | CAAP1 | CASP12 | CASP2 | CASP3 | CASP4 | CASP6 | CASP7 | CASP8 | CASP9 | CCAR1 | CD27 | CDK1 | CFLAR | CHAC1 | CIDEB | CUL1 | CXCR4 | CYCS | DAP3 | DAPK2 | DDIT3 | DEDD2 | DIABLO | E2F1 | EGLN3 | EIF5A | EPO | ERCC3 | ERN1 | FAF1 | FAS | FASLG | FASTK | GADD45A | GADD45B | GADD45G | GZMA | GZMB | HMOX1 | HRAS | HTRA2 | IFNA2 | KMT2A | MAP2K4 | MAP2K6 | MAPK1 | MAPK14 | MAPK3 | MCL1 | MYD88 | NAIP | NCKAP1 | NFKB1 | NFKBIA | NLRP3 | NOTCH2 | OGT | PARP1 | PAWR | PHLDA1 | PMAIP1 | PPARD | PPM1F | PPP1R15A | PRF1 | PRKCD | PSEN1 | PTPN6 | RAF1 | RB1 | RFFL | RIPK1 | RPS6KB1 | SGK1 | SGMS1 | SIVA1 | SNCA | SQSTM1 | STK4 | SUDS3 | TLR2 | TNF | TNFAIP3 | TNFRSF10A | TNFRSF10B | TNFRSF9 | TNFSF10 | TP53 | TRIB3 | TRP53 | USP53 | VDAC1 | WT1 | XAF1 | XBP1 | XIAP
1
1–50 of 520 results.